Trial intelligence / Profile preview

Food effect on pharmacokinetics of TAS-102 in solid tumors

jRCT2080221443Phase 1

Sponsor
Taiho Pharmaceutical Co., Ltd.
Start
Apr 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of trifluridine + tipiracil in Nonhematologic neoplasms, sponsored by Taiho Pharmaceutical Co., Ltd.

02

Drugs

trifluridine + tipiracil
03

Conditions

Nonhematologic neoplasms

Beyond the preview

Go deeper on jRCT2080221443.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080221443.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call